ACI Healthcare USA is the U.S. subsidiary of ACI Limited, a Bangladeshi company, ranking as one of the top pharma companies in Bangladesh and a strong presence in Asia. ACI has established its presence across continents, from Europe to the Middle East and now the United States. ACI Healthcare plans to focus on marketing generic pharmaceuticals and expand its portfolio as the company grows. With the help of a strong parent company to backup our efforts in establishing the company in the United States, we are eager to serve our current customers with world class service and establish relationships with companies we are currently not doing business with. ACI leverages the capabilities of our key partners (ex: contract manufacturer manufacturing our finished product in the United States) while owning the rights (ANDA) over the product. This allows ACI to establish its presence in the United States while earning rapport with 1)Customers 2)FDA 3)Partners. ACI plans to engage in manufacturing their products at their newly built world class facility in Bangladesh which is currently being constructed (near completion), experiencing constant FDA exposure, and preparing for manufacturing products to be sold exclusively in the U.S. market. ACI Healthcare USA is considered the pioneer of Bangladeshi American Pharmaceutical companies, being the first to have a U.S. presence and market generic pharmaceuticals in our own label. The company has grown tremendously since its inception in the United States (2016) due to the capabilities/support provided by our parent company and the various high-profile deeply experienced personnel who have been in the American Pharma industry for over 40 years.